Different binding and degradation of proinsulin, insulin and insulin like growth factor-1 (IGF-1) in cultured renal proximal tubular cells Implications for the prolonged serum half life of proinsulin

Acta Diabetologica

Volumn 33, Issue 2, 1996, Pages 159-165

  Jehle, P M ^a   Fussganger R D ^a   Stracke, S ^a   Grunewald, R W ^b   Keller, F ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Insulin like growth factor 1; Proinsulin; Receptor binding; Renal proximal tubular cells

Indexed keywords

INSULIN; INSULIN RECEPTOR; IODINE 125; PROINSULIN; RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; BINDING AFFINITY; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; DRUG BINDING; DRUG DEGRADATION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; NONHUMAN; PLASMA HALF LIFE; PRIORITY JOURNAL; RABBIT; RECEPTOR BINDING; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0029742835     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00569428     Document Type: Article

References (26)

1. Rinderknecht E, Humbel RE, The amino acid sequence of human insulin-like growth factor I and its structural homolosy to proinsulin. J Biol chem 253:2769-2776, 1978
2. De Meyts P, The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity. and its relevance to mitogenic versus metabolic signalling. Diabetologia 37 [Suppl 21:135-148, 1994
3. Podlecki DA, Frank BH, Olefsky JM, In vitro characterization of biosynthetic human proinsulin. Diabetes 33:111-118, 1984
4. Rausch UW, Fussgaenger RD, Heinze E, Qualitative dissimilarities of insulin and proinsulin binding and action in vitro at IM-9 lymphocytes. Horm Metab Res Suppl 1/88:88-92, 1988
5. Nissley SP, Rechler MM, Moses AC, Short PA, Podskalny JM, Proinsulin binds to a growth peptide receptor and stimulates DNA synthesis in chick embryo fibroblasts. Endocrinology 101:708-716, 1976
6. Schneider DJ, Nordt TK, Sobel BE, Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells. Diabetes 41:890-895, 1992
7. Nordt TK, Schneider DJ, Sobel BE, Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease. Circulation 89:321-330, 1994
8. Duckworth WC, Kitabchi AE, Direct measurement of plasma proinsulin in normal and diabetic subjects. Am J Med 53:418- 427, 1972
9. Cohen RM, Nathan DM, Clements RS, Hyperproinsulinemia in type II diabetes. Diabetes Care 15:723-724, 1992
10. Revers RR, Henry R, Schmeiser L, Schmeiser O, Koltermann R, Cohen R, Bergenstal R, Polonsky KS, Jaspan JB, Rubenstein AH, Frank B, Galloway J, Olefsky JM, The effects of biosynthetic human proinsulin on carbohydrate metabolism Diabetes 33:762-770, 1984
11. Hammerman MR, Interaction of insulin with the renal proximal tubular cell. Am J Physiol 249: F1-F11, 1985
12. Talor Z, Emmanouel DS, Katz AI, Insulin binding and degradation by luminal and basolateral tubular membranes from rat kidney. J Clin Invest 69:1136-1146, 1982
13. Yagil C, Frank BH, Rabkin R, Internalization and catabolism of insulin by an established renal cell line. Am J Physiol 254: C822-C828, 1988
14. Frank BH, Beckage MJ, Willey KA, High-performance liquid chromatographic preparation of single-site carrier-free pancreatic polypeptide hormone radiotracers. J Chromatography 266:239-248, 1983
15. Cheng YC, Prusoff WH, Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction Biochem Pharmacol 22:3099-3108, 1973
16. Hintz RL, Thorsson AV, Enberg G, Hall K, IGF-II binding on human lymphoid cells: Demonstration of a common high affinity receptor for insulin-like peptides. Biochem Biophys Res Commun 118:774-782, 1984
17. Jonas HA, Cox AJ, Insulin receptor subtypes in a human lymphoid-derived cell line (IM-9): Differential regulation by insulin, dexamethasone and monensin. J Recept Res 11:813-829, 1991
18. Blazer-Yost BL, Watanabe M, Haverty TP, Ziyadeh FN, Role of insulin and IGF1 receptors in proliferation of cultured renal proximal tubule cells. Biochim Biophys Acta 1133:329-335, 1992
19. Fussgaenger RD, Ditschuneit HH, Martini H, Wiebauer-De Lenardis H, Etzrodt H, Thun CH, Ditschuneit H, Pfeiffer EF, Enzmann F, Potency of biosynthetic human insulin determined in vitro. Diabetes Care 4:228-234, 1981
20. Jehle PM, Lutz MP, Fussgaenger RD, High affinity binding sites for proinsulin in human IM-9 lymphoblasts. Diabetologia 39:421-432, 1996
21. Rubenstein AH, Pottenger LA, Mako M, Getz GS, Steiner DF, The metabolism of proinsulin and insulin by the liver. J Clin Invest 51:912-921, 1973
22. Kitabchi AE, Proinsulin and C-peptide: a review. Metabolism 26:547-587, 1977
23. Zapf A, Hsu D, Olefsky JM, Comparison of the intracellular itineraries of insulin-like growth factor-I and insulin and their receptors in rat-1 fibroblasts. Endocrinology 134:2445-2452, 1994
24. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clark PMS, Schneider AE, Hales CN, Yudkin JS, The relationships of concentrations of insulin, intact proinsulin, and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin- dependent) diabetic subjects. Diabetologia 33:532-537, 1990
25. Haffner SM, Mykkänen L, Stern MP, Valdez RA, Heisserman JA, Bowsher RR, Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects. Diabetes 42-1297-1302, 1993
26. Reaven GM, Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44:121-131, 1993